Know when to hold ’em, Kenny Rogers taught us. Know when to fold ’em. Know when to walk away. And know when to run. Northrop Grumman CEO Wes Bush evidently knows the song. Mr. Bush has decided to… Read More

If you’ve followed my recommendations for some time now, you know that I utilize a proprietary program I call “CycleProphet,” a market forecasting tool my team developed using decades of research. This sophisticated tool combines and compares peaks and troughs in timewaves with highs and lows in the markets, and has… Read More

Anyone can get lucky once in a while. The same goes for the so-called “experts” on Wall Street. But when the overwhelming majority of experts agree on a handful of stocks, investors should take notice. When a stock has, say, 20 analysts covering it — and all 20 think the… Read More

Interesting data from your federal government: The average wage of the 15.2 million employees in California, according to the U.S. Bureau of Labor Statistics, is $48,090. That’s about $23.12 an hour. Very low on the scale: Private security guards, at $25,950. Also bailiffs, who… Read More

Wednesday I told you what an EPA rule change regarding cellulosic ethanol could mean for the Obama White House and, more important, what it could mean for the shareholders of an ethanol-industry leader. That EPA ruling is a done deal. Another proposed EPA rule… Read More

The trend toward increased worldwide industrialization is undeniable. The growth of China and other emerging markets has exponentially and permanently increased industrial production across the globe. In the past decade, world trade has exploded to a level far beyond what the… Read More

Less than a month ago I told you about what amounted to a rule change at the Environmental Protection Agency (EPA). The Obama administration adjusted an output timetable for the production of cellulosic ethanol, an advanced biofuel. Now, if you didn’t hear this gripping news from me,… Read More

Microcap companies often scare off a lot of investors. Companies with market capitalizations of less than $300 million are seen as volatile and risky. While that’s true for many of them, every once and a while a quality microcap stands out from the crowd. In fact, this little company not… Read More

As a self-confirmed needle-phobe, I try not to glance at those opaque bins in the doctor’s office that are full of used syringes and other such instruments. But looking in the other direction doesn’t change the fact that healthcare facilities go through a mountain of “sharps” every single day. Read More

Insurance stocks often look like lousy investments in a slow economy. Demand for policies can shrink as unemployment rises, and rivals undercut each other on price to snag whatever market share still remains. But you want… Read More